Study on Preliminary Safety and Efficacy of the ARC-IM Therapy to Alleviate Locomotor Deficits in People With Parkinson'
RecruitingNCT06295614Phase: NAStarted 2024-02-14
Summary
The purpose of this clinical trial is to assess the preliminary safety and efficacy of the ARC-IM spinal cord stimulation therapy in alleviating locomotor deficits in individuals with Parkinson's dise
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
None
Locations
Centre Hospitalier Universitaire Vaudois (CHUV)Lausanne, Canton of Vaud, Switzerland
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT06295614